Search

Stephen Johnson

Examiner (ID: 7683, Phone: (571)272-6877 , Office: P/3641 )

Most Active Art Unit
3641
Art Unit(s)
2201, 3641
Total Applications
3122
Issued Applications
2552
Pending Applications
138
Abandoned Applications
437

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 6214510 [patent_doc_number] => 20110136898 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-06-09 [patent_title] => 'TREATMENT OF RETINAL DEGENERATION' [patent_app_type] => utility [patent_app_number] => 13/057548 [patent_app_country] => US [patent_app_date] => 2009-08-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 6112 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0136/20110136898.pdf [firstpage_image] =>[orig_patent_app_number] => 13057548 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/057548
TREATMENT OF RETINAL DEGENERATION Aug 4, 2009 Abandoned
Array ( [id] => 5959630 [patent_doc_number] => 20110184017 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-07-28 [patent_title] => 'STABLE AQUEOUS SOLUTION COMPOSITION CONTAINING SULFONAMIDE COMPOUND' [patent_app_type] => utility [patent_app_number] => 13/055031 [patent_app_country] => US [patent_app_date] => 2009-07-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 13064 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0184/20110184017.pdf [firstpage_image] =>[orig_patent_app_number] => 13055031 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/055031
STABLE AQUEOUS SOLUTION COMPOSITION CONTAINING SULFONAMIDE COMPOUND Jul 23, 2009 Abandoned
Array ( [id] => 8005293 [patent_doc_number] => 08084047 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-12-27 [patent_title] => 'Compositions and methods for treatment of eye disorders' [patent_app_type] => utility [patent_app_number] => 12/508367 [patent_app_country] => US [patent_app_date] => 2009-07-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 33743 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/084/08084047.pdf [firstpage_image] =>[orig_patent_app_number] => 12508367 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/508367
Compositions and methods for treatment of eye disorders Jul 22, 2009 Issued
Array ( [id] => 6480402 [patent_doc_number] => 20100092541 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-04-15 [patent_title] => 'COMPOSITIONS AND METHODS FOR TREATMENT OF EYE DISORDERS' [patent_app_type] => utility [patent_app_number] => 12/508311 [patent_app_country] => US [patent_app_date] => 2009-07-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 33745 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0092/20100092541.pdf [firstpage_image] =>[orig_patent_app_number] => 12508311 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/508311
COMPOSITIONS AND METHODS FOR TREATMENT OF EYE DISORDERS Jul 22, 2009 Abandoned
Array ( [id] => 5474472 [patent_doc_number] => 20090247638 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-10-01 [patent_title] => 'PHARMACEUTICAL USE OF COX-2-INHIBITORS IN ANGIOGENESIS-MEDIATED OCULAR DISORDERS' [patent_app_type] => utility [patent_app_number] => 12/481609 [patent_app_country] => US [patent_app_date] => 2009-06-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4668 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0247/20090247638.pdf [firstpage_image] =>[orig_patent_app_number] => 12481609 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/481609
PHARMACEUTICAL USE OF COX-2-INHIBITORS IN ANGIOGENESIS-MEDIATED OCULAR DISORDERS Jun 9, 2009 Abandoned
Array ( [id] => 6616559 [patent_doc_number] => 20100310614 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-09 [patent_title] => 'Stannous Chloride Compositions' [patent_app_type] => utility [patent_app_number] => 12/480236 [patent_app_country] => US [patent_app_date] => 2009-06-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 3902 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0310/20100310614.pdf [firstpage_image] =>[orig_patent_app_number] => 12480236 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/480236
Stannous chloride compositions Jun 7, 2009 Issued
Array ( [id] => 5404961 [patent_doc_number] => 20090240276 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-09-24 [patent_title] => 'Gel Plug For Blockage Of The Canaliculus' [patent_app_type] => utility [patent_app_number] => 12/478700 [patent_app_country] => US [patent_app_date] => 2009-06-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 5569 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0240/20090240276.pdf [firstpage_image] =>[orig_patent_app_number] => 12478700 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/478700
Gel Plug For Blockage Of The Canaliculus Jun 3, 2009 Abandoned
Array ( [id] => 6628096 [patent_doc_number] => 20100172995 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-08 [patent_title] => 'Process For Preparing A Solid Pharmaceutical Composition' [patent_app_type] => utility [patent_app_number] => 12/477727 [patent_app_country] => US [patent_app_date] => 2009-06-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2415 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0172/20100172995.pdf [firstpage_image] =>[orig_patent_app_number] => 12477727 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/477727
Process For Preparing A Solid Pharmaceutical Composition Jun 2, 2009 Abandoned
Array ( [id] => 12506454 [patent_doc_number] => 09999593 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-06-19 [patent_title] => Method and composition for treating ocular hypertension and glaucoma [patent_app_type] => utility [patent_app_number] => 12/995351 [patent_app_country] => US [patent_app_date] => 2009-05-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 4 [patent_no_of_words] => 2958 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 63 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12995351 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/995351
Method and composition for treating ocular hypertension and glaucoma May 27, 2009 Issued
Array ( [id] => 6434749 [patent_doc_number] => 20100278897 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-04 [patent_title] => 'INTRAOCULAR BIOACTIVE AGENT DELIVERY SYSTEM WITH MOLECULAR PARTITIONING SYSTEM' [patent_app_type] => utility [patent_app_number] => 12/434541 [patent_app_country] => US [patent_app_date] => 2009-05-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 12031 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0278/20100278897.pdf [firstpage_image] =>[orig_patent_app_number] => 12434541 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/434541
INTRAOCULAR BIOACTIVE AGENT DELIVERY SYSTEM WITH MOLECULAR PARTITIONING SYSTEM Apr 30, 2009 Abandoned
Array ( [id] => 5464461 [patent_doc_number] => 20090324661 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-31 [patent_title] => 'NIACINAMIDE CONTAINING COSMETIC COMPOSITIONS WITH IMPROVED SKINFEEL PROPERTIES' [patent_app_type] => utility [patent_app_number] => 12/432065 [patent_app_country] => US [patent_app_date] => 2009-04-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5804 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0324/20090324661.pdf [firstpage_image] =>[orig_patent_app_number] => 12432065 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/432065
NIACINAMIDE CONTAINING COSMETIC COMPOSITIONS WITH IMPROVED SKINFEEL PROPERTIES Apr 28, 2009 Abandoned
Array ( [id] => 7651970 [patent_doc_number] => 20110301239 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-08 [patent_title] => 'USE OF NOVEL LIPID MEDIATORS TO INHIBIT ANGIOGENESIS' [patent_app_type] => utility [patent_app_number] => 12/989626 [patent_app_country] => US [patent_app_date] => 2009-04-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 25270 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0301/20110301239.pdf [firstpage_image] =>[orig_patent_app_number] => 12989626 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/989626
USE OF NOVEL LIPID MEDIATORS TO INHIBIT ANGIOGENESIS Apr 26, 2009 Abandoned
Array ( [id] => 5391247 [patent_doc_number] => 20090208560 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-08-20 [patent_title] => 'Cover material and plaster with cover material' [patent_app_type] => utility [patent_app_number] => 12/385935 [patent_app_country] => US [patent_app_date] => 2009-04-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 6033 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0208/20090208560.pdf [firstpage_image] =>[orig_patent_app_number] => 12385935 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/385935
Cover material and plaster with cover material Apr 23, 2009 Abandoned
Array ( [id] => 5457805 [patent_doc_number] => 20090257957 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-10-15 [patent_title] => 'Aerosolized LFA-1 antagonists for use in localized treatment of immune related disorders' [patent_app_type] => utility [patent_app_number] => 12/386363 [patent_app_country] => US [patent_app_date] => 2009-04-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 29 [patent_figures_cnt] => 29 [patent_no_of_words] => 48018 [patent_no_of_claims] => 61 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0257/20090257957.pdf [firstpage_image] =>[orig_patent_app_number] => 12386363 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/386363
Aerosolized LFA-1 antagonists for use in localized treatment of immune related disorders Apr 14, 2009 Abandoned
Array ( [id] => 5457918 [patent_doc_number] => 20090258070 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-10-15 [patent_title] => 'Topical LFA-1 antagonists for use in localized treatment of immune related disorders' [patent_app_type] => utility [patent_app_number] => 12/386359 [patent_app_country] => US [patent_app_date] => 2009-04-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 30 [patent_figures_cnt] => 30 [patent_no_of_words] => 46311 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0258/20090258070.pdf [firstpage_image] =>[orig_patent_app_number] => 12386359 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/386359
Topical LFA-1 antagonists for use in localized treatment of immune related disorders Apr 14, 2009 Abandoned
Array ( [id] => 5973102 [patent_doc_number] => 20110152328 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-06-23 [patent_title] => 'Combination Therapy For Glaucoma' [patent_app_type] => utility [patent_app_number] => 12/988168 [patent_app_country] => US [patent_app_date] => 2009-04-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 466583 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0152/20110152328.pdf [firstpage_image] =>[orig_patent_app_number] => 12988168 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/988168
Combination Therapy For Glaucoma Apr 12, 2009 Abandoned
Array ( [id] => 5538797 [patent_doc_number] => 20090220602 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-09-03 [patent_title] => 'SUBLIMABLE SUSTAINED RELEASE DELIVERY SYSTEM AND METHOD OF MAKING SAME' [patent_app_type] => utility [patent_app_number] => 12/417119 [patent_app_country] => US [patent_app_date] => 2009-04-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 8286 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0220/20090220602.pdf [firstpage_image] =>[orig_patent_app_number] => 12417119 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/417119
Sublimable sustained release delivery system and method of making same Apr 1, 2009 Issued
Array ( [id] => 7800690 [patent_doc_number] => 08128960 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-03-06 [patent_title] => 'Low viscosity, highly flocculated triamcinolone acetonide suspensions for intravitreal injection' [patent_app_type] => utility [patent_app_number] => 12/401168 [patent_app_country] => US [patent_app_date] => 2009-03-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4363 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 143 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/128/08128960.pdf [firstpage_image] =>[orig_patent_app_number] => 12401168 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/401168
Low viscosity, highly flocculated triamcinolone acetonide suspensions for intravitreal injection Mar 9, 2009 Issued
Array ( [id] => 5502862 [patent_doc_number] => 20090163550 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-06-25 [patent_title] => 'RETINOID-CONTAINING SUSTAINED RELEASE INTRAOCULAR IMPLANTS AND RELATED METHODS' [patent_app_type] => utility [patent_app_number] => 12/388400 [patent_app_country] => US [patent_app_date] => 2009-02-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 50 [patent_figures_cnt] => 50 [patent_no_of_words] => 23598 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0163/20090163550.pdf [firstpage_image] =>[orig_patent_app_number] => 12388400 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/388400
RETINOID-CONTAINING SUSTAINED RELEASE INTRAOCULAR IMPLANTS AND RELATED METHODS Feb 17, 2009 Abandoned
Array ( [id] => 8549388 [patent_doc_number] => 08324270 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-12-04 [patent_title] => 'Methods for the treatment and prevention of age-related retinal dysfunction' [patent_app_type] => utility [patent_app_number] => 12/368427 [patent_app_country] => US [patent_app_date] => 2009-02-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 11 [patent_no_of_words] => 13325 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 66 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12368427 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/368427
Methods for the treatment and prevention of age-related retinal dysfunction Feb 9, 2009 Issued
Menu